FH Ortho
James Hook has over 30 years of work experience in the medical technology industry. James has held various senior positions in multiple companies, including FH Orthopedics where they are currently the Managing Director. Prior to that, they served as the Senior Vice President, North American Sales at Small Bone Innovations, Inc. from 2008 to 2011. James was also the General Manager at Tornier from 2002 to 2008 and the Vice President of Marketing at Novametrix from 2000 to 2001. James started their career at Wright Medical Technology where they served as the Vice President of Sales and Marketing for over 16 years, from 1984 to 2000.
James Hook completed their Bachelor of Science (B.S.) in Environmental Biology from Furman University from 1967 to 1971. James then pursued a Master of Science (M.S.) in Vertebrate Zoology from the University of Denver from 1971 to 1974. Later, from 1981 to 1983, they attended The Wharton School, where they obtained a Business Management Program Diploma, specializing in Business.
This person is not in any teams
This person is not in any offices
FH Ortho
FH Ortho has been achieving rapid growth in the US orthopedic implant market, well-positioned as a surgeon-focused innovator and first-mover in areas of shoulder arthroplasty, calcaneal fracture fixation, and soft-tissue reconstructions in the knee. The Arrow® Prime Dual-Platform Shoulder System expands the options of the successful Arrow Universal Shoulder System, offering surgeons a cementless, metal-back anatomic glenoid option, with a clinically-proven design that addresses the most common failure modality in total shoulder arthroplasty; glenoid loosening. Supported by 14 years of successful clinical history, Arrow® Prime offers surgeons unparalleled intraoperative flexibility, dual-platform interchangeability, and addresses the continuum of indications for shoulder arthroplasty in an efficient, 4-tray instrument system. FH Ortho’s Calcanail® represents a novel, percutaneous approach for the treatment of calcaneal pathologies. An intramedullary nail, it offers a tissue-sparing approach for the address of tuberosity displacements, intra-articular fracture reduction, and arthrodesis when indicated. Coupled with advanced instrumentation, this guided-approach puts clinical efficacy and ease-of-use in the surgeon’s hands. The CoLS® system is a revolutionary approach to soft-tissue repair in the knee, engineered to counter principal short-comings that impact other methods. The CoLS® system is redefining the “gold standard” with short, precise tunnels, a pre-tensioned semitendinosus graft that guards against future laxity, and a robust method of fixation that favors healing. To learn more about Arrow® Prime, CoLS®, and Calcanail®, please visit www. fhortho.com.